Anglo-French Drugs & Industries Ltd
52W HIGH
Rs 1,898.63
52W LOW
Rs 1,319.39
1Y RETURN
+22.0%
About the Company
Anglo-French Drugs & Industries is a pharmaceutical manufacturer with a product portfolio spanning APIs, formulations, and OTC medicines for domestic and export markets.
Quick Facts
As of 7 Jul 2026
Quantity
Minimum investment Rs 1,00,000 (63 shares).
Settled in T+1 days. KYC verified dealers.
Get Anglo-French Drugs & Industries Ltd's live price
Share a few details and our desk sends you the latest price, availability and how to invest.
Trusted by 5,000+ investors · your details are never shared.
FUNDAMENTALS
Key Indicators
A snapshot of Anglo-French Drugs & Industries Ltd's valuation multiples and capital efficiency at a glance.
CURRENT SHARE PRICE
Rs 1,609.01
FACE VALUE / SHARE
Rs 10
BOOK VALUE / SHARE
Rs 1,195.84
PRICE TO EARNING (PE)
0.00
PRICE / BOOK
0.00
MARKET CAP
181.82 Cr
DEBT TO EQUITY
0.15
RETURN ON EQUITY
12%
52 WEEK HIGH
Rs 1,898.63
52 WEEK LOW
Rs 1,319.39
FINANCIALS
Fundamentals & Financial Statements
P/E Ratio
0.00
P/B Ratio
0.00
Debt to Equity
0.15
Book Value
₹1,195.84
Face Value
₹10
| Particulars | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 103 | 95 | 88 |
| Cost of Material Consumed | 68 | 70 | 68 |
| Change in Inventory | 9.5 | -2 | -0.5 |
| Gross Margins | 24.76% | 28.42% | 23.3% |
| Employee Benefit Expenses | 23 | 19 | 18 |
| Other Expenses | 43 | 19 | 19 |
| EBITDA | -40.5 | -11 | -16.5 |
| OPM | -39.32% | -11.58% | -18.75% |
| Other Income | 299 | 5 | 30 |
| Finance Cost | 3 | 2 | 2 |
| Depreciation & Amortisation | 3.3 | 3 | 3 |
| EBIT | -43.8 | -14 | -19.5 |
| EBIT Margins | -42.52% | -14.74% | -22.16% |
| Profit Before Tax | 251 | -12 | 8 |
| PBT Margins | 243.69% | -12.63% | 9.09% |
| Tax | 60 | 0 | 0 |
| Profit After Tax | 191 | -12 | 8 |
| Net Profit Margin | 185.44% | -12.63% | 9.09% |
| EPS | ₹1,480.62 | ₹-97.56 | ₹70.8 |
PROCESS
How to Buy Anglo-French Drugs & Industries Ltd
Enquire
Share your requirement and preferred quantity with our desk.
Get a quote
Receive the latest indicative price, lot size and availability.
Complete KYC
Quick paperwork with a KYC-verified counterparty.
Receive shares
Shares credited to your demat, typically within T+1 days.
OWNERSHIP
Shareholding Pattern
Indicative ownership structure. Exact filed breakup confirmed at dealing.
CORPORATE CALENDAR
Events & Announcements
Typical annual calendar. Exact dates updated as the company announces them.
LEADERSHIP
Management Team
Standard governance structure. Named directors added as verified. Tap any role to see what they do and why it matters for investors.
REPORTS
Download Financial Results
Anglo-French Drugs & Industries Ltd Financial Report
Fundamentals, financial statements and key ratios in one PDF
Need the official filed reports?
Get audited annual & quarterly filings (MCA / RTA) for Anglo-French Drugs & Industries Ltd straight from our desk.
QUESTIONS
Frequently Asked Questions
NEWS & INSIGHTS
Latest on Anglo-French Drugs & Industries Ltd & its sector
CORPORATE
Company Details
ISIN
N/A
CIN
L24230KA1923PLC010205
PAN
AAACA9756E
REGISTRAR (RTA)
Canbank Computer Services
SECTOR
Healthcare
INDUSTRY
Pharmaceuticals
READY TO INVEST?
Enquire with Neoma Capital
Talk to a CA advisor about Anglo-French Drugs & Industries Ltd. Get pricing, availability, and transfer process guidance.
Disclaimer: Prices shown are indicative and for reference purposes only. Unlisted shares carry higher risk than listed equities. Past performance is not indicative of future results. Financial statements, where shown, are compiled from company filings (MCA / RTA) and may be restated in subsequent filings. Neoma Capital does not provide investment advice. Please consult a qualified financial advisor. Transactions subject to KYC verification and SEBI regulations.